These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22476945)

  • 21. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature.
    Sekimizu M; Sunami S; Nakazawa A; Hayashi Y; Okimoto Y; Saito AM; Horibe K; Tsurusawa M; Mori T
    Br J Haematol; 2011 Sep; 154(5):612-7. PubMed ID: 21689091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-lymphoblastic leukemia/lymphoma.
    You MJ; Medeiros LJ; Hsi ED
    Am J Clin Pathol; 2015 Sep; 144(3):411-22. PubMed ID: 26276771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    De Bie J; Quessada J; Tueur G; Lefebvre C; Luquet I; Toujani S; Cuccuini W; Lafage-Pochitaloff M; Michaux L
    Curr Res Transl Med; 2023; 71(4):103431. PubMed ID: 38016418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.
    Bayón-Calderón F; Toribio ML; González-García S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haploidentical/mismatched hematopoietic stem cell transplantation without in vitro T cell depletion for T cell acute lymphoblastic leukemia.
    Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Zhang XH; Huang XJ
    Biol Blood Marrow Transplant; 2012 May; 18(5):716-21. PubMed ID: 21924223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.
    Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
    Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.
    Patel AA; Thomas J; Rojek AE; Stock W
    Curr Treat Options Oncol; 2020 May; 21(7):57. PubMed ID: 32468488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.
    Heilmann AM; Schrock AB; He J; Nahas M; Curran K; Shukla N; Cramer S; Draper L; Verma A; Erlich R; Ross J; Stephens P; Miller VA; Ali SM; Verglio JA; Tallman MS; Mughal TI
    Leukemia; 2017 Sep; 31(9):1989-1992. PubMed ID: 28552906
    [No Abstract]   [Full Text] [Related]  

  • 34. Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine?
    Young KH
    Leukemia; 2020 Apr; 34(4):1213-1214. PubMed ID: 31641192
    [No Abstract]   [Full Text] [Related]  

  • 35. Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies.
    Morita-Fujita M; Arai Y; Yoshioka S; Ishikawa T; Kanda J; Kondo T; Akasaka T; Ueda Y; Imada K; Moriguchi T; Yago K; Kitano T; Yonezawa A; Nohgawa M; Takaori-Kondo A;
    Sci Rep; 2020 Dec; 10(1):21418. PubMed ID: 33293600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.
    Xu L; Weng J; Huang X; Zeng C; Chen S; Geng S; Yang L; Wu S; Huang S; Du X; Li Y
    Oncotarget; 2016 Jul; 7(28):42943-42952. PubMed ID: 27356746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
    Hefazi M; Litzow MR
    Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
    Gökbuget N; Basara N; Baurmann H; Beck J; Brüggemann M; Diedrich H; Güldenzoph B; Hartung G; Horst HA; Hüttmann A; Kobbe G; Naumann R; Ratei R; Reichle A; Serve H; Stelljes M; Viardot A; Wattad M; Hoelzer D
    Blood; 2011 Sep; 118(13):3504-11. PubMed ID: 21715318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early T-cell precursor acute lymphoblastic leukaemia.
    Haydu JE; Ferrando AA
    Curr Opin Hematol; 2013 Jul; 20(4):369-73. PubMed ID: 23695450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.
    Koschmieder S; Burmeister T; Brüggemann M; Berkemeier A; Volpert S; Wieacker P; Silling G; Gökbuget N; Müller-Tidow C; Berdel WE; Stelljes M
    Leukemia; 2014 Feb; 28(2):419-22. PubMed ID: 24048416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.